FDAnews
www.fdanews.com/articles/97970-biovail-receives-canadian-approval-for-ralivia

Biovail Receives Canadian Approval for Ralivia

September 4, 2007

Biovail Corporation announced that the Therapeutic Products Directorate (TPD) Canada has issued a Notice of Compliance (NOC) for 100mg, 200mg and 300mg tablet strengths of Ralivia, the Company’s once-daily, extended-release formulation of tramadol hydrochloride indicated for the management of pain of moderate severity in patients who require continuous treatment for several days or more.
Yahoo! Finance